Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia ; volume:238 ; number:10 ; day:20 ; month:8 ; year:2021 ; pages:2693-2708 ; date:10.2021
Psychopharmacology ; 238, Heft 10 (20.8.2021), 2693-2708, 10.2021
- Urheber
-
Roch, Catherine
Bergamini, Giorgio
Steiner, Michel A.
Clozel, Martine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-021-05954-0
- URN
-
urn:nbn:de:101:1-2021112918065891089791
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roch, Catherine
- Bergamini, Giorgio
- Steiner, Michel A.
- Clozel, Martine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Synthesis of Dual Orexin Receptor Antagonist MK-6096
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
Daridorexant bei chronischer Insomnie : der duale Orexin-Rezeptor-Antagonist als Therapieoption ohne zeitliche Einschränkung bei der langfristigen Verordnung
Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist